JazzAgree MON sits on a knife edge. They need to deliver performance improvement and increased ounces.My current MON holding is peanuts in comparison to the other goldies I hold.Though in saying that i just got hit at 0.50 ....lol
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025